OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
EGFR pathway targeting drugs in head and neck cancer in the era of immunotherapy
James Kang, Albert I. Ko, Sang Hoon Kil, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188827-188827
Closed Access | Times Cited: 23
James Kang, Albert I. Ko, Sang Hoon Kil, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2022) Vol. 1878, Iss. 1, pp. 188827-188827
Closed Access | Times Cited: 23
Showing 23 citing articles:
Recent Advancements, Limitations, and Future Perspectives of the use of Personalized Medicine in Treatment of Colon Cancer
Amit Dey, Abhijit Mitra, Surajit Pathak, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 50
Amit Dey, Abhijit Mitra, Surajit Pathak, et al.
Technology in Cancer Research & Treatment (2023) Vol. 22
Open Access | Times Cited: 50
Emerging histological and serological biomarkers in oral squamous cell carcinoma: Applications in diagnosis, prognosis evaluation and personalized therapeutics (Review)
Leonel Pekarek, Maria J. Garrido-Gil, Alicia Sánchez‐Cendra, et al.
Oncology Reports (2023) Vol. 50, Iss. 6
Open Access | Times Cited: 27
Leonel Pekarek, Maria J. Garrido-Gil, Alicia Sánchez‐Cendra, et al.
Oncology Reports (2023) Vol. 50, Iss. 6
Open Access | Times Cited: 27
Pharmacological impact of microRNAs in head and neck squamous cell carcinoma: Prevailing insights on molecular pathways, diagnosis, and nanomedicine treatment
Bedanta Bhattacharjee, Ayesha Farhana Syeda, Damanbhalang Rynjah, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Bedanta Bhattacharjee, Ayesha Farhana Syeda, Damanbhalang Rynjah, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 19
Effects of saponins from Chinese herbal medicines on signal transduction pathways in cancer: A review
Mingtao Zhu, Yanping Sun, Haodong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Mingtao Zhu, Yanping Sun, Haodong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 12
Design, Synthesis, and Biological Evaluation of Newly Synthesized Cinnamide-Fluorinated Containing Compounds as Bioactive Anticancer Agents
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18505-18515
Open Access | Times Cited: 3
Dalal Nasser Binjawhar, Fawziah A. Al‐Salmi, Maha Al‐Ghamdi, et al.
ACS Omega (2024) Vol. 9, Iss. 16, pp. 18505-18515
Open Access | Times Cited: 3
Cetuximab chemotherapy resistance: Insight into the homeostatic evolution of head and neck cancer (Review)
Carlos Henrique Diniz, Tiago Henrique, Ana Carolina Buzzo Stefanini, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
Carlos Henrique Diniz, Tiago Henrique, Ana Carolina Buzzo Stefanini, et al.
Oncology Reports (2024) Vol. 51, Iss. 6
Open Access | Times Cited: 3
A synthetic molecule targeting STAT3 against human oral squamous cell carcinoma cells
Li-Yuan Bai, Eman M.E. Dokla, Po‐Chen Chu, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 5, pp. 1081-1091
Open Access
Li-Yuan Bai, Eman M.E. Dokla, Po‐Chen Chu, et al.
International Journal of Medical Sciences (2025) Vol. 22, Iss. 5, pp. 1081-1091
Open Access
Decoding driver and phenotypic genes in cancer: Unveiling the essence behind the phenomenon
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
Dequan Liu, Lei Liu, Xiaoman Zhang, et al.
Molecular Aspects of Medicine (2025) Vol. 103, pp. 101358-101358
Open Access
Research progress of nanomaterials in tumor-targeted drug delivery and imaging therapy
Liuru Fang, Yuhua Wang, Zu-zhao Xiong, et al.
OpenNano (2023) Vol. 14, pp. 100184-100184
Open Access | Times Cited: 8
Liuru Fang, Yuhua Wang, Zu-zhao Xiong, et al.
OpenNano (2023) Vol. 14, pp. 100184-100184
Open Access | Times Cited: 8
Study protocol: phase II study to evaluate the effect of cetuximab monotherapy after immunotherapy with PD-1 inhibitors in patients with head and neck squamous cell cancer
Kimberly M. Burcher, Chance H. Bloomer, Elena Gavrila, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Kimberly M. Burcher, Chance H. Bloomer, Elena Gavrila, et al.
Therapeutic Advances in Medical Oncology (2024) Vol. 16
Open Access | Times Cited: 2
Evaluation of Co-Inhibition of ErbB Family and PI3K Kinases for HPV-Negative Head and Neck Squamous Cell Carcinoma
Hancai Dan, Xinyan Geng, Shirin Azarbarzin, et al.
(2024)
Open Access | Times Cited: 2
Hancai Dan, Xinyan Geng, Shirin Azarbarzin, et al.
(2024)
Open Access | Times Cited: 2
Ciprofloxacin and Norfloxacin Hybrid Compounds: Potential Anticancer Agents
Sijongesonke Peter, Blessing A. Aderibigbe
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 644-665
Closed Access | Times Cited: 2
Sijongesonke Peter, Blessing A. Aderibigbe
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 7, pp. 644-665
Closed Access | Times Cited: 2
Differential modulation of PI3K /Akt/mTOR activity by EGFR inhibitors: A rationale for co‐targeting EGFR and PI3K in cisplatin‐resistant HNSCC
Jipei Liao, Zejia Yang, Shirin Azarbarzin, et al.
Head & Neck (2024) Vol. 46, Iss. 5, pp. 1126-1135
Closed Access | Times Cited: 2
Jipei Liao, Zejia Yang, Shirin Azarbarzin, et al.
Head & Neck (2024) Vol. 46, Iss. 5, pp. 1126-1135
Closed Access | Times Cited: 2
Exploring the Therapeutic Implications of Co-Targeting the EGFR and Spindle Assembly Checkpoint Pathways in Oral Cancer
Mafalda Calheiros-Lobo, João P. N. Silva, Bárbara Pinto, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1196-1196
Open Access | Times Cited: 2
Mafalda Calheiros-Lobo, João P. N. Silva, Bárbara Pinto, et al.
Pharmaceutics (2024) Vol. 16, Iss. 9, pp. 1196-1196
Open Access | Times Cited: 2
Current status and future prospects of combined immunotherapy and epidermal growth factor receptor inhibitors in head and neck squamous cell carcinoma
Xin Tian, Hongyan Zhang, Yiman Han, et al.
Cancer Treatment Reviews (2024) Vol. 132, pp. 102864-102864
Closed Access | Times Cited: 1
Xin Tian, Hongyan Zhang, Yiman Han, et al.
Cancer Treatment Reviews (2024) Vol. 132, pp. 102864-102864
Closed Access | Times Cited: 1
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HNSCC
Khalid N.M. Abdelazeem, Diemmy Nguyen, Sophia Corbo, et al.
Oncogene (2024)
Open Access | Times Cited: 1
Khalid N.M. Abdelazeem, Diemmy Nguyen, Sophia Corbo, et al.
Oncogene (2024)
Open Access | Times Cited: 1
Biochemical separation of Cetuximab-Fab from papain-digested antibody fragments and radiolabeling with 64Cu for potential use in radioimmunotheranostics
Rubel Chakravarty, Nanda Rohra, Sachin Jadhav, et al.
Applied Radiation and Isotopes (2023) Vol. 196, pp. 110795-110795
Closed Access | Times Cited: 3
Rubel Chakravarty, Nanda Rohra, Sachin Jadhav, et al.
Applied Radiation and Isotopes (2023) Vol. 196, pp. 110795-110795
Closed Access | Times Cited: 3
Iontophoresis-Driven Alterations in Nanoparticle Uptake Pathway and Intracellular Trafficking in Carcinoma Skin Cancer Cells
Gabriela Fávero Galvão, Raquel Petrilli, Vanessa Cristina Arfelli, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 248, pp. 114459-114459
Closed Access
Gabriela Fávero Galvão, Raquel Petrilli, Vanessa Cristina Arfelli, et al.
Colloids and Surfaces B Biointerfaces (2024) Vol. 248, pp. 114459-114459
Closed Access
Exploration of Molecular Targets and Mechanisms of Curcumin in the Treatment of COVID-19 with Depression by an Integrative Pharmacology Strategy
Dongwei Zhu, Xianmei Zhou
Current Pharmaceutical Design (2023) Vol. 29, Iss. 31, pp. 2501-2519
Closed Access | Times Cited: 1
Dongwei Zhu, Xianmei Zhou
Current Pharmaceutical Design (2023) Vol. 29, Iss. 31, pp. 2501-2519
Closed Access | Times Cited: 1
Investigating the activity of Quinazoline derivatives against T790 mutant EGFR receptors employing computer-aided drug design
Deepika Dinesh Adottu, Afanamol Mankulathil Shajahan, Shifa Ali Koolaparambil, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access
Deepika Dinesh Adottu, Afanamol Mankulathil Shajahan, Shifa Ali Koolaparambil, et al.
Journal of Applied Pharmaceutical Science (2024)
Open Access
Manipulating the EphB4-ephrinB2 axis to reduce metastasis in HSNCC
Khalid N.M. Abdelazeem, Diemmy Nguyen, Sophia Corbo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Khalid N.M. Abdelazeem, Diemmy Nguyen, Sophia Corbo, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Identification of Biomarkers for Diagnosis and Prognosis of Head and Neck Cancer: Bioinformatics Approach
Alexandra Fernandes, Rui Vitorino
Targets (2024) Vol. 2, Iss. 4, pp. 470-480
Open Access
Alexandra Fernandes, Rui Vitorino
Targets (2024) Vol. 2, Iss. 4, pp. 470-480
Open Access
Radiation Therapy Improves Survival in Patients with Distant Metastatic Head and Neck Squamous Cell Carcinoma: A Retrospective Study
Mengwen Wang, Baitian Zhao, A. Huang, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 996-1007
Open Access
Mengwen Wang, Baitian Zhao, A. Huang, et al.
Journal of Cancer (2024) Vol. 16, Iss. 3, pp. 996-1007
Open Access
